Effect of breast cancer adjuvant therapies on potential biomarkers of pulmonary inflammation.

@article{Piperis2012EffectOB,
  title={Effect of breast cancer adjuvant therapies on potential biomarkers of pulmonary inflammation.},
  author={Maria Piperis and Xeni Provatopoulou and Alexandros Sagkriotis and Eleni Kalogera and Emmanouil Ampatzoglou and George Nikolaos Zografos and Eleni Athanasiou and Antonia Gounaris},
  journal={Anticancer research},
  year={2012},
  volume={32 11},
  pages={4993-5002}
}
BACKGROUND The aim of this study was to investigate the effect of breast cancer adjuvant therapies on the levels of circulating surfactant protein-D (SP-D), C-Reactive protein (CRP) and soluble receptor for advanced glycation end-products (sRAGE), as potential biomarkers of subclinical pulmonary inflammation. MATERIALS AND METHODS The soluble molecules were serially determined in 38 patients, prior to the initiation of radiation therapy (RT) and during adjuvant treatment, using immunoassays… CONTINUE READING